Solvay Zukünftiges Wachstum
Future Kriterienprüfungen 4/6
Der Umsatz von Solvay wird voraussichtlich um 1.2% pro Jahr zurückgehen, während der Jahresgewinn um 44.9% pro Jahr wachsen soll. Der Gewinn je Aktie wird voraussichtlich um 37.7% pro Jahr steigen. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 37.9% betragen.
Wichtige Informationen
44.9%
Wachstumsrate der Gewinne
37.70%
EPS-Wachstumsrate
| Chemicals Gewinnwachstum | 30.7% |
| Wachstumsrate der Einnahmen | -1.2% |
| Zukünftige Eigenkapitalrendite | 37.88% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 18 Sep 2026 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Narrative-Update • Jul 10
SOLB: Rare Earth Capabilities And Rating Upgrade May Support Future Upside
Analysts have trimmed their fair value estimate for Solvay from €32 to €30, pointing to adjusted revenue growth and profit margin assumptions, while also reflecting recent changes in Street price targets that now cluster around €26 to €30. Analyst Commentary Recent research on Solvay shows a mix of caution and growing optimism, with some bullish analysts highlighting specific business capabilities and updated price targets as potential support for the current valuation debate.Narrative-Update • Jun 26
SOLB: Rare Earth Capabilities And Patent Ruling Will Support Upside Potential
Analysts now set Solvay’s fair value at €32, down from €37. This reflects a more cautious view on revenue growth and profit margins, even as some expect the company’s rare earth capabilities to support shareholder value over time.Analyseartikel • Jun 17
Solvay (ENXTBR:SOLB) Stock Could Be 8.8% Overvalued After European Patent Win
The European Patent Office has upheld Solvay (ENXTBR:SOLB)’s key European patent covering its soda ash purge stream recycling process after a challenge from WE Soda Ltd, putting the company’s intellectual property position firmly in focus for investors. See our latest analysis for Solvay. Solvay’s recent patent win comes at a time when the stock’s 7-day share price return of 5.98% and 30-day share price return of 4.12% sit against a 1-year total shareholder return that is down 3.84%, while...
Narrative-Update • Jun 11
SOLB: Rare Earth Supply Plans And Mixed Ratings Will Shape Fair Value Outlook
Narrative Update The analyst price target for Solvay is now set at €25.10. This move is supported by recent Street research, where analysts highlight the company’s rare earth capabilities and adjust targets in a €26 to €30 range, while fine tuning assumptions around discount rates, modest revenue declines, profit margins and future P/E expectations.Narrative-Update • May 28
SOLB: Mixed Ratings And Higher P/E Assumptions Will Shape Fair Value Outlook
Solvay's analyst price target has been trimmed by about €0.40 to reflect slightly lower fair value and profit margin assumptions, even as analysts factor in a higher future P/E multiple based on recent research updates. Analyst Commentary The latest round of research on Solvay points to a mixed view, with some analysts trimming price targets while others see room for the stock to trade at higher levels relative to earnings.Narrative-Update • Apr 19
SOLB: Mixed Ratings And Slightly Lower Assumptions Will Shape Fair Value Outlook
Solvay's analyst price target has edged down by about €0.13 as analysts adjust their fair value and P/E assumptions, reflecting recent target moves and downgrades from several banks while still incorporating some upward revisions from others. Analyst Commentary Recent research updates show a split view on Solvay, with some analysts lifting price targets while several others cut targets or downgraded their stance.Narrative-Update • Apr 02
SOLB: Trimmed Expectations And Mixed Ratings Will Still Support Fair Value
Solvay's analyst price target has been trimmed by about €0.25, as analysts factor in softer revenue expectations, slightly higher margin assumptions and a lower future P/E multiple. Analyst Commentary Recent Street research on Solvay points to a cautious stance, with several firms trimming price targets or downgrading ratings while a few still see upside at specific levels.Narrative-Update • Mar 19
SOLB: Rare Earth Role Will Offset Execution Risks And Support Fair Value
Analysts have nudged Solvay's fair value estimate slightly lower to about €25.72 per share. This reflects a mix of reduced profit margin assumptions, a modestly lower discount rate, and updated external price targets that now cluster in the €22 to €28 range.Narrative-Update • Mar 04
SOLB: Rare Earth Supply Role Will Temper Softer Outlook And Downgrades
Narrative Update on Solvay Our updated analyst price target for Solvay edges down slightly to €25.78 from €25.88. This reflects a modest recalibration of expected growth and margins, even as recent Street research has shifted targets in a tight €22 to €28 range with several downgrades and cautious P/E assumptions from analysts.Narrative-Update • Feb 18
SOLB: Rare Earth Supply Role Will Offset Softer Outlook And Downgrades
Analysts have reduced their price target on Solvay to about €25.88 from roughly €26.44, reflecting a series of recent downgrades and slightly softer assumptions for revenue, margins and fair value multiples. Analyst Commentary Bullish Takeaways Bullish analysts still see upside to the current share price, with some targets such as €28 and €27 implying room for rerating if execution on cost discipline and portfolio focus holds up.Narrative-Update • Feb 03
SOLB: Rare Earth Partnerships Will Counter Softer Outlook And Cautious Ratings
Analysts have trimmed their price targets on Solvay, with our fair value estimate moving from €27.19 to €26.44 as they factor in slightly softer revenue expectations, a higher discount rate, and lower assumed future P/E multiples, partly offset by firmer profit margin assumptions. Analyst Commentary Recent Street research on Solvay has leaned more cautious, with several firms lowering price targets and moving to more neutral or negative ratings as they reassess the risk and reward profile.Narrative-Update • Jan 19
SOLB: Rare Earth Agreements Will Offset Softer Outlook At A Fair Price
Analysts have nudged their Solvay price target slightly lower to about €27.19 from about €27.27, reflecting updated views on slower revenue trends, a higher discount rate, better profit margins, and a lower future P/E assumption, alongside recent target cuts and rating changes from several research houses. Analyst Commentary Recent research opinions around Solvay cluster around cautious updates to price targets and ratings, with most commentary focusing on how current execution and growth expectations line up against existing valuations.Narrative-Update • Jan 05
SOLB: Rare Earth Agreements Will Steady Execution Risks At A Fair Price
Analysts have trimmed their price target on Solvay to about €23.50, a modest reset that reflects slightly lower profit margin expectations while keeping fair value and P/E assumptions broadly in line with prior views. Analyst Commentary Recent research points to a slightly lower fair value marker for Solvay at about €23.50, which still sits close to prior assumptions on P/E and overall valuation.Narrative-Update • Dec 14
SOLB: Rare Earth Agreements Will Offset Softer Outlook And Heightened Execution Risks
Analysts trimmed their fair value estimate for Solvay by about EUR 0.50 per share, reflecting slightly higher perceived risk and softer long term growth expectations, in line with a series of recent price target cuts across the Street. Analyst Commentary Recent Street updates reflect a cautious stance on Solvay, with a series of modest price target reductions signaling tempered expectations for both earnings growth and valuation upside.Narrative-Update • Nov 29
SOLB: Near-Term Outlook Will Hinge On Margin Resilience Amid Industry Pressures
Solvay’s analyst price target was modestly reduced from €27.80 to €27.73. Analysts cite ongoing cautiousness around revenue growth and margin pressures, which are reflected in several recent downward revisions.Narrative-Update • Nov 15
SOLB: Future Performance Will Depend On Profit Margin Recovery And Cost Discipline
Solvay's analyst price target was reduced from €28.70 to €27.80, as analysts cited a more cautious outlook on revenue growth and profit margins in recent research updates. Analyst Commentary Analyst sentiment toward Solvay has shifted in recent research updates, with several firms lowering their price targets and highlighting both positive and negative drivers that could influence the company’s near-term performance.Narrative-Update • Oct 31
SOLB: Recent Macroeconomic Pressures Will Shape Outlook Amid Stable Fundamentals
Narrative Update on Solvay Solvay’s analyst price target has been lowered slightly, from €28.97 to €28.70, as analysts cite modestly higher discount rates and slightly weaker revenue growth outlooks in their recent updates. Analyst Commentary Recent updates from analysts have provided a nuanced view of Solvay's outlook, highlighting both areas of potential and ongoing challenges that may affect its future performance.Narrative-Update • Oct 17
La Rochelle Expansion And Energy Transition Will Secure Future Success
Analysts have modestly reduced their price target for Solvay, lowering it by a small margin in response to recent Street research. The research cites softer profit margins and ongoing revenue pressures, resulting in updated targets between EUR 25.50 and EUR 27.Narrative-Update • Oct 03
La Rochelle Expansion And Energy Transition Will Secure Future Success
Solvay's analyst price target has been revised downward by approximately EUR 0.80 per share. Analysts cite ongoing revenue pressure and updated profit margin forecasts to support the adjustment.Narrative-Update • Sep 04
La Rochelle Expansion And Energy Transition Will Secure Future Success
Analysts have maintained a cautious outlook on Solvay due to persistent input cost inflation, margin pressure, and weak European demand, resulting in conservative earnings estimates and an unchanged consensus price target of €29.83. Analyst Commentary Cautious sentiment persists due to slower organic growth outlook in core businesses.Analyseartikel • Jan 24
Risks To Shareholder Returns Are Elevated At These Prices For Solvay SA (EBR:SOLB)
It's not a stretch to say that Solvay SA's ( EBR:SOLB ) price-to-sales (or "P/S") ratio of 0.6x right now seems quite...Analyseartikel • Jan 06
Solvay (EBR:SOLB) Will Pay A Dividend Of €0.679
The board of Solvay SA ( EBR:SOLB ) has announced that it will pay a dividend on the 22nd of January, with investors...
Neues Narrative • Dec 25
Green River Expansion And Hydrogen Peroxide Licensing Propel Earnings Growth
Expansion of Green River facility and sustainability efforts position Solvay to benefit from future revenue growth and attract environmentally conscious customers.Analyseartikel • Dec 21
Solvay's (EBR:SOLB) Dividend Will Be €0.679
Solvay SA's ( EBR:SOLB ) investors are due to receive a payment of €0.679 per share on 22nd of January. The dividend...Analyseartikel • Oct 17
Solvay SA (EBR:SOLB) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected
Solvay SA ( EBR:SOLB ) shareholders would be excited to see that the share price has had a great month, posting a 25...Analyseartikel • Sep 18
Are Investors Undervaluing Solvay SA (EBR:SOLB) By 43%?
Key Insights Solvay's estimated fair value is €57.91 based on 2 Stage Free Cash Flow to Equity Solvay is estimated to...Analyseartikel • Aug 28
Solvay SA's (EBR:SOLB) Share Price Could Signal Some Risk
It's not a stretch to say that Solvay SA's ( EBR:SOLB ) price-to-sales (or "P/S") ratio of 0.6x right now seems quite...Analyseartikel • Aug 08
Solvay's (EBR:SOLB) Earnings May Just Be The Starting Point
Solvay SA's ( EBR:SOLB ) earnings announcement last week was disappointing for investors, despite the decent profit...Analyseartikel • Jul 14
Solvay (EBR:SOLB) Has A Somewhat Strained Balance Sheet
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Analyseartikel • Jun 14
Are Investors Undervaluing Solvay SA (EBR:SOLB) By 37%?
Key Insights Using the 2 Stage Free Cash Flow to Equity, Solvay fair value estimate is €50.62 Current share price of...Analyseartikel • May 29
Is It Too Late To Consider Buying Solvay SA (EBR:SOLB)?
While Solvay SA ( EBR:SOLB ) might not have the largest market cap around , it led the ENXTBR gainers with a relatively...Analyseartikel • Apr 24
Solvay SA (EBR:SOLB) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected
Solvay SA ( EBR:SOLB ) shareholders have had their patience rewarded with a 26% share price jump in the last month...Analyseartikel • Mar 10
Solvay SA's (EBR:SOLB) Business And Shares Still Trailing The Market
Solvay SA's ( EBR:SOLB ) price-to-earnings (or "P/E") ratio of 2.3x might make it look like a strong buy right now...Analyseartikel • Nov 20
Is Solvay SA (EBR:SOLB) Trading At A 28% Discount?
Key Insights Solvay's estimated fair value is €144 based on 2 Stage Free Cash Flow to Equity Current share price of...Analyseartikel • Nov 06
Solvay (EBR:SOLB) Is Increasing Its Dividend To €1.13
Solvay SA ( EBR:SOLB ) will increase its dividend from last year's comparable payment on the 17th of January to €1.13...Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2028 | 4,300 | 268 | 312 | 671 | 8 |
| 12/31/2027 | 4,206 | 246 | 252 | 579 | 10 |
| 12/31/2026 | 4,104 | 187 | 202 | 535 | 10 |
| 6/30/2026 | 4,574 | 4 | 403 | 625 | N/A |
| 3/31/2026 | 4,645 | -25 | 445 | 660 | N/A |
| 12/31/2025 | 4,746 | 30 | 462 | 682 | N/A |
| 9/30/2025 | 4,906 | 154 | 293 | 596 | N/A |
| 6/30/2025 | 4,954 | 139 | 243 | 551 | N/A |
| 3/31/2025 | 5,075 | 197 | 298 | 590 | N/A |
| 12/31/2024 | 5,130 | 223 | 330 | 615 | N/A |
| 9/30/2024 | 5,218 | -64 | 196 | 618 | N/A |
| 6/30/2024 | 5,338 | 18 | 404 | 1,102 | N/A |
| 3/31/2024 | 5,571 | 127 | 804 | 1,731 | N/A |
| 12/31/2023 | 6,025 | -37 | 847 | 1,911 | N/A |
| 9/30/2023 | 497 | -384 | 1,162 | 2,372 | N/A |
| 6/30/2023 | 3,542 | -34 | 1,178 | 2,252 | N/A |
| 3/31/2023 | 6,038 | 495 | 977 | 1,945 | N/A |
| 12/31/2022 | 7,979 | 889 | 1,097 | 2,006 | N/A |
| 9/30/2022 | 15,442 | 1,859 | 998 | 1,775 | N/A |
| 6/30/2022 | 13,895 | 1,659 | 1,001 | 1,723 | N/A |
| 3/31/2022 | 12,523 | 1,176 | 897 | 1,578 | N/A |
| 12/31/2021 | 11,434 | 943 | 863 | 1,499 | N/A |
| 9/30/2021 | 10,575 | 648 | 927 | 1,440 | N/A |
| 6/30/2021 | 9,982 | 608 | 1,028 | 1,482 | N/A |
| 3/31/2021 | 9,631 | -1,168 | 1,158 | 1,603 | N/A |
| 12/31/2020 | 9,714 | -1,125 | 707 | 1,242 | N/A |
| 9/30/2020 | 10,006 | -1,216 | 771 | 1,408 | N/A |
| 6/30/2020 | 10,514 | -1,872 | 726 | 1,496 | N/A |
| 3/31/2020 | 11,055 | -134 | N/A | 1,585 | N/A |
| 12/31/2019 | 11,227 | -118 | N/A | 1,815 | N/A |
| 9/30/2019 | 11,347 | 111 | N/A | 2,081 | N/A |
| 6/30/2019 | 11,409 | 764 | N/A | 1,863 | N/A |
| 3/31/2019 | 11,349 | 767 | N/A | 1,572 | N/A |
| 12/31/2018 | 11,299 | 676 | N/A | 1,720 | N/A |
| 9/30/2018 | 11,187 | 775 | N/A | 1,582 | N/A |
| 6/30/2018 | 10,987 | 748 | N/A | 1,623 | N/A |
| 3/31/2018 | 10,953 | 730 | N/A | 1,649 | N/A |
| 12/31/2017 | 10,984 | 820 | N/A | 1,590 | N/A |
| 9/30/2017 | 10,851 | 771 | N/A | 1,602 | N/A |
| 6/30/2017 | 10,694 | 765 | N/A | 1,718 | N/A |
| 3/31/2017 | 10,057 | 717 | N/A | 1,800 | N/A |
| 12/31/2016 | 10,044 | 539 | N/A | 1,788 | N/A |
| 9/30/2016 | 9,168 | 317 | N/A | 1,694 | N/A |
| 6/30/2016 | 9,512 | 248 | N/A | 1,572 | N/A |
| 3/31/2016 | 10,146 | 220 | N/A | 1,626 | N/A |
| 12/31/2015 | 10,083 | 355 | N/A | 1,289 | N/A |
| 9/30/2015 | 11,068 | 325 | N/A | 1,591 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: SOLBDas prognostizierte Gewinnwachstum (44.9% pro Jahr) liegt über der Sparquote (2.6%).
Ertrag vs. Markt: SOLBDie Erträge des Unternehmens (44.9% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Belgian (11.6% pro Jahr).
Hohe Wachstumserträge: SOLBEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.
Einnahmen vs. Markt: SOLBDie Einnahmen des Unternehmens werden in den nächsten 3 Jahren voraussichtlich zurückgehen (-1.2% pro Jahr).
Hohe Wachstumseinnahmen: SOLBDie Einnahmen des Unternehmens werden in den nächsten drei Jahren voraussichtlich zurückgehen (-1.2% pro Jahr).
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: SOLBDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich hoch sein (37.9%)
Wachstumsunternehmen entdecken
Unternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/09/18 22:52 |
| Aktienkurs zum Tagesende | 2026/09/18 00:00 |
| Gewinne | 2026/06/30 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Details zum Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite; außerdem bieten wir Leitfäden zur Nutzung unserer Berichte und Tutorials auf Youtube an.
Erfahren Sie mehr über das , das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
Solvay SA wird von 39 Analysten beobachtet. 10 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Katie Richards | Barclays |
| James Stewart | Barclays |
| Andreas Heine | Barclays |